Bone-To-Implant Contact At 4- And 6-Week Healing Stages in Implants With Different Surfaces.
Bone-To-Implant Contact At 4- And 6-Week Healing Stages in Implants Having Either Machined, SLA Medium Roughness, Nanostructured Calcium-Incorporated or Plasma Reactivated Nanostructured Calcium-Incorporated Surface: A Histologic Study.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Beirut, Lebanon
- Saint Joseph University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Height of the residual bone crest in the programmed implant site ≥ 9 mm and thickness ≥ 7mm.
- Availability, in each sector, of sufficient mesio-distal space allowing placement of 2 standard-sized implants and at least 2 mini-implants (3.5x8.5mm) for retrieval.
- Healed bone crest (≥ 3 months elapsed after extraction or tooth loss).
- Age > 18 years.
- Ability to examine and fully understand the study protocol.
Exclusion Criteria:
• Myocardial infarction within the past 6 months.
- Poorly controlled diabetes (HBA1c > 7.5%).
- Coagulation disorders.
- Radiotherapy to the head/neck area within the past two years.
- Present or past treatment with intravenous bisphosphonates.
- Immunocompromised patients.
- Psychological or psychiatric problems.
- Alcohol or drug abuse.
- Poor oral hygiene and motivation (full mouth plaque score > 30% and/or full mouth bleeding score > 20%).
- Uncontrolled periodontal disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Xpeed
Implant with Xpeed surface
|
Implant placement with different surface types
|
|
Active Comparator: SLA surface
Implant with SLA surface
|
Implant placement with different surface types
|
|
Placebo Comparator: Machined
Implant with machined surface
|
Implant placement with different surface types
|
|
Active Comparator: XPEEDActive
Implant with plasma treatment reactivated XPEED implant surface
|
Implant placement with different surface types
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone to implant contact
Time Frame: 4 weeks healing period after implant placement
|
Histology technique on specimen retrieved containing mini-implants and bone surrounding it
|
4 weeks healing period after implant placement
|
|
Bone to implant contact
Time Frame: 6 weeks healing period after implant placement
|
Histology technique on specimen retrieved containing mini-implants and bone surrounding it
|
6 weeks healing period after implant placement
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Christian Makary, Phd, Saint Joseph University - Beirut
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- XFMD171
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.